Decrease of urinary nerve growth factor levels after antimuscarinic therapy in patients with overactive bladder

BJU International

Volumn 103, Issue 12, 2009, Pages 1668-1672

  Liu, Hsin Tzu ^b   Chancellor, Michael B ^a   Kuo, Hann Chorng ^b,c  

^a WILLIAM BEAUMONT HOSPITAL   (United States)

^b TZU CHI UNIVERSITY   (Taiwan)

^c BUDDHIST TZU CHI GENERAL HOSPITAL   (Taiwan)

Author keywords

Increased bladder sensation; Lower urinary tract symptoms; Nerve growth factor; Overactive bladder

Indexed keywords

BIOLOGICAL MARKER; CREATININE; NERVE GROWTH FACTOR; TOLTERODINE;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MICTURITION; OVERACTIVE BLADDER; POSTVOID RESIDUAL URINE VOLUME; PRIORITY JOURNAL; TREATMENT OUTCOME; URINARY URGENCY; URINE FLOW RATE; URINE LEVEL;

ADULT; AGED; AGED, 80 AND OVER; BENZHYDRYL COMPOUNDS; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CRESOLS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; MALE; MIDDLE AGED; MUSCARINIC ANTAGONISTS; NERVE GROWTH FACTOR; PHENYLPROPANOLAMINE; PROGNOSIS; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME; URINARY BLADDER, OVERACTIVE; URODYNAMICS;

EID: 66449108462     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2009.08380.x     Document Type: Article

References (20)

1. Abrams P, Kelleher CJ, Kerr LA, Rogers RG. Overactive bladder significantly affects quality of life. Am J Manag Care 2000 6 (Suppl. S580 90
2. Andersson KE, Wein AJ. Pharmacology of the lower urinary tract: basis for current and future treatments of urinary incontinence. Pharmacol Rev 2004 56 : 581 631 (Pubitemid 40003785)
3. de Groat WC, Booth AM, Yoshimura N. Neurophysioloy of micturition and its modification in animal models of human disease. In Maggie CA, The Autonomic Nervous System, Vol. 6, Chapter 8 : Nervous Control of the Urogenital System. London : Harwood Academic Publishers, 1993 : 227 89
4. Yoshida M, Inadome A, Maeda Y et al. Non-neuronal cholinergic system in human bladder urothelium. Urology 2006 67 : 425 30
5. 3 muscarinic receptors in human bladder disorders and their clinical correlations. J Urol 2006 176 : 367 73
6. Kim Y, Yoshimura N, Masuda H, de Miguel F, Chancellor MB. Antimuscarinic agents exhibit local inhibitory effects on muscarinic receptors in bladder afferent pathways. Urology 2005 65 : 238 42
7. Liu HT, Kuo HC. Urinary nerve growth factor level could be a potential biomarker for diagnosis of overactive bladder. J Urol 2008 179 : 2270 4
8. Kim JC, Park EY, Seo SI, Park YH, Hwang TK. Nerve growth factor and prostaglandins in the urine of female patients with overactive bladder. J Urol 2006 175 : 1773 6
9. Nixon A, Colman S, Sabounjian L et al. A validated patient reported measure of urinary urgency severity in overactive bladder for use in clinical trials. J Urol 2005 174 : 604 7
10. Abrams P, Cardozo L, Fall M et al. The standardisation of terminology of lower urinary tract function: report from the Standardisation Sub-committee of the International Continence Society. Neurourol Urodyn 2002 21 : 167 78
11. Steers WD, Kolbeck S, Creedon D, Tuttle JB. Nerve growth factor in the urinary bladder of the adult regulates neuronal form and function. J Clin Invest 1991 88 : 1709 15
12. Dupont MC, Spitsberegen JM, Kim KB, Tuttle JB, Steers WD. Histological and neurotrophic changes triggered by varying models of bladder inflammation. J Urol 2001 166 : 1111 8
13. Lowe EM, Anand P, Terenghi G, Williams-Chestnut RE, Sinicropi DV, Osborne JL. Increased nerve growth factor levels in the urinary bladder of women with idiopathic sensory urgency and interstitial cystitis. Br J Urol 1997 79 : 572 7
14. Yokoyama T, Kumon H, Nagai A. Correlation of urinary nerve growth factor level with pathogenesis of overactive bladder. Neurourol Urodyn 2008 27 : 417 20
15. Birder LA, Wolf-Johnston A, Griffiths D, Resnick NM. Role of urothelial nerve growth factor in human bladder function. Neurourol Urodyn 2007 26 : 405 9
16. 3 and TRPV1 in suburothelial nerve fibers following intradetrusor injections of botulinum toxin for human detrusor overactivity. J Urol 2005 174 : 977 83
17. Giannantoni A, Di Stasi SM, Nardicchi V et al. Botulinum-A toxin injections into the detrusor decrease nerve growth factor bladder tissue levels in patients with neurogenic detrusor overactivity. J Urol 2006 175 : 2341 4
18. Andersson KE, Yoshida M. Antimuscarinics and the overactive detrusor - which is the main mechanism of action? Eur Urol 2003 43 : 1 5 (Pubitemid 36134308)
19. Finney SM, Andersson KE, Gillespie JI, Stewart LH. Antimuscarinic drugs in detrusor overactivity and the overactive bladder syndrome: motor or sensory actions? BJU Int 2006 98 : 503 7
20. Steers WD. Pathophysiology of overactive bladder and urge urinary incontinence. Rev Urol 2002 4 (Suppl. 4 S7 18